New brain scan study seeks clues to rare gaucher disease
NCT ID NCT05586243
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study uses a special MRI technique called magnetic resonance spectroscopy to measure brain chemicals in adults with Type 3 Gaucher disease. The goal is to find markers that show how the disease affects the brain and how it responds to treatment. About 5 participants aged 18 and older will join this observational study at the University of Minnesota.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GAUCHER DISEASE, TYPE 3 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we outsmart Gaucher's hidden toll on lungs, bones, and brain?
- New pill aims to tackle rare genetic disorder affecting brain and body
- Could a pill replace infusions for gaucher brain symptoms?
- Gene therapy injection aims to control rare brain disease in children
- Cough medicine repurposed: ambroxol registry launches for rare brain diseases
- Groundbreaking trial aims to treat rare diseases in the womb